AustinPx, LLC is a client-centric contract development and manufacturing organization (CDMO) based in Georgetown, TX. They specialize in helping developers overcome obstacles in bringing their drug candidates to market, including poor bioavailability and accelerated timelines. With a team of formulation, analytical, and manufacturing experts, AustinPx simplifies the complexity of outsourcing and works closely with clients to identify opportunities and overcome challenges, offering solutions-driven development services.
AustinPx is known for their innovative approach and data-driven strategies, focusing on the unique physiochemical characteristics of each drug molecule and the goals of their clients. They are pioneers in the field of pharmaceutics, and their KinetiSol Technology, a next-generation amorphous solid dispersion (ASD) technology for poorly soluble APIs, sets them apart in the industry. With a smaller ecological footprint, faster processing times, and wider application to challenging molecules, AustinPx aims to disrupt the ASD industry and help developers realize the full potential of their drug candidates.
Generated from the website